NOSOCOMIAL AND HEALTHCARE RELATED INFECTIONS: Edited by Trish M. PerlCandida aurisSaris, Katjaa,b; Meis, Jacques F.a,c,d; Voss, Andreasa,b,dAuthor Information aDepartment of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital (CWZ) bRadboudumc, REshape Center for Innovation cCentre of Expertise in Mycology Radboudumc/Canisius-Wilhelmina Hospital dDepartment of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands Correspondence to Andreas Voss, MD, PhD, Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital (CWZ), Postbus 9015 C70 MMB, Nijmegen 6500 GS, Netherlands. Tel: +31 24 365 81 67; e-mail: [email protected] Current Opinion in Infectious Diseases: August 2018 - Volume 31 - Issue 4 - p 334-340 doi: 10.1097/QCO.0000000000000469 Buy Metrics Abstract Purpose of review To give an update on the recent emergence of Candida auris. Recent findings C. auris is a pathogen, that evades present therapeutic options, that is highly virulent, causes disease in all types of patients, and spreads easily in the environment and among patients, thereby posing an imminent threat to our patients. The fact that C. auris, in addition, is more resilient to environmental disinfection and frequently misclassified during microbiological diagnostics only heightens its potential as a ‘perfect villain.’ Summary Healthcare institutions, especially hospitals, need to ensure that their diagnostic and infection control policies to handle C. auris are in place. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.